How the Breast Cancer Risk Calculator Works
This calculator combines two pieces of published, well-established data: an age-specific baseline 10-year breast cancer risk (drawn from National Cancer Institute SEER population statistics) and a set of relative-risk multipliers for common risk factors from epidemiological research. It multiplies your age-specific baseline by the combined multiplier for your inputs to produce an adjusted, educational risk estimate. It is a simplified model, not the validated clinical Gail model (NCI Breast Cancer Risk Assessment Tool) or the Tyrer-Cuzick model that clinicians use, and it should never replace a real clinical risk assessment.
The baseline: age-specific population risk
Breast cancer risk rises steadily with age. Based on SEER national data, the average U.S. woman's chance of a breast cancer diagnosis in the next 10 years is roughly 0.1% at age 20, 0.5% at age 30, 1.5% at age 40, 2.3% at age 50, 3.5% at age 60, and about 4.1% at age 70 and beyond. The calculator interpolates between these published reference points for your exact age. Average lifetime risk from birth is about 13%, or roughly 1 in 8 women.
Relative-risk multipliers applied to your inputs
Each input adjusts that baseline using multipliers drawn from pooled research: one first-degree relative (mother, sister, or daughter) with breast cancer multiplies risk by about 1.8x, and two or more relatives by about 2.9x (Collaborative Group on Hormonal Factors in Breast Cancer). An earlier first period (before age 12) adds a small multiplier, as does having a first child at 30 or older or never giving birth. A prior benign biopsy multiplies risk by roughly 1.5x, while a biopsy showing atypical hyperplasia — an abnormal but non-cancerous cell pattern — multiplies risk by roughly 4x (Dupont & Page cohort data). These multipliers are combined and applied to your age-specific baseline and to the average lifetime risk to produce the adjusted estimates.
What this model leaves out
This simplified estimator does not account for BRCA1/BRCA2 or other genetic mutation status, breast density on mammography, menopausal hormone therapy use, alcohol intake, body weight, race/ethnicity-specific baseline rates, or age at menopause — all factors a full clinical risk model or genetic counselor would consider. It also does not diagnose cancer or predict an individual outcome; it produces a population-based estimate only.
When to seek a clinical risk assessment
If you have a strong family history of breast or ovarian cancer, a known BRCA1/BRCA2 mutation in your family, a personal history of chest radiation, or any breast symptom (a lump, skin changes, nipple discharge), talk to a doctor or genetic counselor promptly rather than relying on this or any online estimate. Screening mammography guidelines and any decision about earlier or more frequent screening should come from a healthcare provider who knows your full history.